node,neighbor,type
10.1002/cbdv.200800342,"Cytotoxic activity against human leukemia (MOLT-4), melanoma (MDA-MB-435), colon (HCT-8), and glyoblastoma (SF-295) cancer cell lines, and against L-929 (normal fibroblasts).",doi_bioActivity
10.1002/cbdv.200800342,Cytotoxic activity against human tumor cell lines.,doi_bioActivity
10.1002/cbdv.200800342,Cytotoxic activity against human tumor cell lines.,doi_bioActivity
10.1002/cbdv.200800342,Cytotoxic activity against human tumor cell lines.,doi_bioActivity
10.1002/cbdv.200800342,Cytotoxic activity against human tumor cell lines.,doi_bioActivity
10.1002/cbdv.200800342,"Strongest cytotoxicity against all tumor cell lines tested, compared to normal L-929 cells. Comparable with the positive control doxorubicin.",doi_bioActivity
10.1002/cbdv.200800342,"No cytotoxic activity to cancer cells, indicating that the presence of these CO groups at C(18) and C(19) is incompatible with the cytotoxic activity. Derived from degradation of casearin X in CDCl3.",doi_bioActivity
10.1002/jobm.200800093,Weak cytotoxic activity against tumor cell lines,doi_bioActivity
10.1002/jobm.200800093,Moderate cytotoxic activity against tumor cell lines when combined with Compound 5,doi_bioActivity
10.1002/jobm.200800093,"Weak cytotoxic activity, potential synergy with Compound 4",doi_bioActivity
10.1002/jobm.200800093,Remarkable cytotoxic activity against tumor cell lines,doi_bioActivity
10.1002/jobm.200800093,Not mentioned,doi_bioActivity
10.1002/jobm.200800093,Cytotoxic activity not mentioned,doi_bioActivity
10.1002/ps.1278,"Moderate larval weight loss in Spodoptera frugiperda after 10 days of treatment, suggesting some antifeedant or toxicity effect, but further details are not mentioned",doi_bioActivity
10.1002/ps.1278,Possible feeding deterrence causing larval weight loss in Spodoptera frugiperda,doi_bioActivity
10.1002/ps.1278,"High larval mortality in Spodoptera frugiperda, suggest insecticidal or antifeedant properties",doi_bioActivity
10.1002/ps.1278,High larval mortality in Spodoptera frugiperda,doi_bioActivity
10.1002/ps.1278,Possible feeding deterrence causing larval weight loss in Spodoptera frugiperda similar to tannin's bioactivity,doi_bioActivity
10.1016/0031-9422(91)85077-D,"Inhibited the growth of Aspergillus niger, Cladosporium cladosporioides, and Colletotrichum gloeosporioides; fungitoxic properties",doi_bioActivity
10.1016/0040-4020(95)00254-6,Active in a mechanism-based DNA-modifying yeast assay and cytotoxic in Vero monkey and Chinese hamster ovary cell assays,doi_bioActivity
10.1016/0040-4020(95)00254-6,Moderately active in Vero monkey and Chinese hamster ovary cell cytotoxicity assays,doi_bioActivity
10.1016/0040-4020(95)00254-6,Unknown specific bioactivity from the provided data,doi_bioActivity
10.1016/0040-4020(95)00254-6,Assumed bioactive but no specific bioactivity profile provided,doi_bioActivity
10.1016/0040-4020(95)00254-6,Assumed bioactive but no specific bioactivity profile provided,doi_bioActivity
10.1016/0040-4020(95)00254-6,Unknown specific bioactivity from the provided data,doi_bioActivity
10.1016/0040-4020(95)00254-6,Assumed bioactive but no specific bioactivity profile provided,doi_bioActivity
10.1016/S0031-9422(00)00226-0,Antifungal activity against Cladosporium sphaerospermum,doi_bioActivity
10.1016/S0031-9422(00)00226-0,Antifungal activity against Cladosporium sphaerospermum,doi_bioActivity
10.1016/S0031-9422(00)00248-X,weak inhibitor,doi_bioActivity
10.1016/S0031-9422(00)00248-X,weak inhibitor,doi_bioActivity
10.1016/S0031-9422(00)00248-X,weak inhibitor,doi_bioActivity
10.1016/S0031-9422(00)00248-X,not specified,doi_bioActivity
10.1016/S0031-9422(00)00248-X,"comparable to mixture of Molecule_6 and Molecule_7 in inhibiting enzymatic activity by 99% at 100 mg/ml, IC50 value of 81 µM",doi_bioActivity
10.1016/S0031-9422(00)00248-X,part of mixture with Molecule_7; completely inhibited enzymatic activity (by 100%) at 100 mg/ml,doi_bioActivity
10.1016/S0031-9422(00)00248-X,part of mixture with Molecule_6; completely inhibited enzymatic activity (by 100%) at 100 mg/ml,doi_bioActivity
10.1016/S0031-9422(00)00477-5,antioxidant activity,doi_bioActivity
10.1016/S0031-9422(00)00477-5,antioxidant activity,doi_bioActivity
10.1016/S0031-9422(00)00477-5,inhibiting the bleaching of β-carotene,doi_bioActivity
10.1016/S0031-9422(00)00477-5,antioxidant activity,doi_bioActivity
10.1016/S0031-9422(00)00477-5,inhibiting the bleaching of β-carotene,doi_bioActivity
10.1016/S0031-9422(00)00477-5,inhibiting the bleaching of β-carotene,doi_bioActivity
10.1016/S0031-9422(01)00079-6,Potent inhibition against strains of Saccharomyces cerevisiae and fungi Cladosporium cladosporioides and C. sphaerospermum,doi_bioActivity
10.1016/S0031-9422(01)00079-6,Potent inhibition against strains of Saccharomyces cerevisiae and fungi Cladosporium cladosporioides and C. sphaerospermum,doi_bioActivity
10.1016/S0031-9422(01)00079-6,Potent inhibition against strains of Saccharomyces cerevisiae and fungi Cladosporium cladosporioides and C. sphaerospermum,doi_bioActivity
10.1016/S0031-9422(01)00079-6,Potent inhibition against strains of Saccharomyces cerevisiae and fungi Cladosporium cladosporioides and C. sphaerospermum; previously reported anticancer activity,doi_bioActivity
10.1016/S0031-9422(01)00079-6,Marginal activity against fungal growth of Cladosporium cladosporioides and C. sphaerospermum,doi_bioActivity
10.1016/S0031-9422(01)00079-6,Low or no activity against fungal growth of Cladosporium cladosporioides and C. sphaerospermum,doi_bioActivity
10.1016/S0031-9422(01)00079-6,Marginal activity against fungal growth of Cladosporium cladosporioides and C. sphaerospermum,doi_bioActivity
10.1016/S0031-9422(03)00153-5,In vitro activity against trypomastigote forms of Trypanosoma cruzi with IC50 value of 59.0 mg/mL,doi_bioActivity
10.1016/S0031-9422(03)00153-5,In vitro activity against trypomastigote forms of Trypanosoma cruzi with IC50 value of 90.2 mg/mL,doi_bioActivity
10.1016/S0031-9422(03)00153-5,In vitro activity against trypomastigote forms of Trypanosoma cruzi,doi_bioActivity
10.1016/S0031-9422(98)00249-0,"DNA-damaging activity, selective activity in the Rad 52Y and RS 321 yeast assay compared with the wild type Rad+ strain",doi_bioActivity
10.1016/S0031-9422(98)00249-0,"DNA-damaging activity, selective activity in the Rad 52Y and RS 321 yeast assay compared with the wild type Rad+ strain",doi_bioActivity
10.1016/S0031-9422(98)00249-0,"DNA-damaging activity, selective activity in the Rad 52Y and RS 321 yeast assay compared with the wild type Rad+ strain",doi_bioActivity
10.1016/j.bmc.2010.12.056,"Moderate inhibitor of cathepsin V with competitive inhibition mechanism, IC50 value of 2.5 ± 0.2 µM, Ki value of 0.5 µM",doi_bioActivity
10.1016/j.bmc.2010.12.056,"Potent and reversible inhibitor of cathepsin V with competitive inhibition mechanism, IC50 value of 3.9 ± 0.9 µM, Ki value of 1.2 µM",doi_bioActivity
10.1016/j.bmc.2010.12.056,"Inhibitor of cathepsin V with competitive inhibition mechanism, IC50 value of 2.2 ± 0.2 µM, Ki value of 1.1 µM",doi_bioActivity
10.1016/j.bmc.2010.12.056,"Inhibitor of cathepsin V with competitive inhibition mechanism, IC50 value of 25 ± 5 µM, Ki value of 10.0 µM",doi_bioActivity
10.1016/j.bmc.2010.12.056,"Moderate inhibitor of cathepsin V with competitive inhibition mechanism, IC50 value of 10 ± 1 µM, Ki value of 4.2 µM",doi_bioActivity
10.1016/j.bmc.2010.12.056,"Potent inhibitor of cathepsin V with competitive inhibition mechanism, IC50 value of 2.2 ± 0.6 µM, Ki value of 1.0 µM",doi_bioActivity
10.1016/j.bmc.2010.12.056,"Most potent inhibitor in series of cathepsin V with competitive inhibition mechanism, IC50 value of 1.2 ± 0.1 µM, Ki value of 0.2 µM",doi_bioActivity
10.1016/j.bmc.2010.12.056,"Inhibitor of cathepsin V, IC50 value of 48 ± 5 µM",doi_bioActivity
10.1016/j.bmc.2010.12.056,"Inhibitor of cathepsin V, IC50 value of 44 ± 3 µM",doi_bioActivity
10.1016/j.bmc.2010.12.056,"Potent inhibitor of cathepsin V with competitive mechanism, IC50 value of 5.2 ± 0.2 µM, Ki value of 4.4 µM",doi_bioActivity
10.1016/j.bmc.2010.12.056,"Potent inhibitor of cathepsin V with competitive inhibition mechanism, IC50 value of 2.8 ± 0.7 µM, Ki value of 1.7 µM",doi_bioActivity
10.1016/j.bse.2006.06.007,Antifungal; Comparable activity to nystatin against C. cladosporioides and C. sphaerospermum,doi_bioActivity
10.1016/j.bse.2006.06.007,Antifungal; Comparable activity to nystatin against C. cladosporioides and C. sphaerospermum,doi_bioActivity
10.1016/j.jep.2007.09.020,"anti-inflammatory, potential preventive effect against kidney stone",doi_bioActivity
10.1016/j.jep.2007.09.020,"anti-inflammatory, potential preventive effect against kidney stone",doi_bioActivity
10.1016/j.jep.2007.09.020,"anti-inflammatory, preventive effect against kidney stone",doi_bioActivity
10.1016/j.jep.2007.09.020,"anti-inflammatory, preventive effect against kidney stone",doi_bioActivity
10.1016/j.jep.2007.09.020,"anti-inflammatory, antinociceptive and antioxidant",doi_bioActivity
10.1016/j.jep.2007.09.020,"anti-inflammatory, antinociceptive and antioxidant",doi_bioActivity
10.1016/j.jep.2007.09.020,"anti-inflammatory, antinociceptive and antioxidant",doi_bioActivity
10.1016/j.jep.2007.09.020,"anti-inflammatory, antinociceptive and antioxidant",doi_bioActivity
10.1016/j.jfca.2003.09.013,Antioxidant; free radical scavenging activity,doi_bioActivity
10.1016/j.jfca.2003.09.013,Antioxidant; free radical scavenging activity,doi_bioActivity
10.1016/j.jfca.2003.09.013,Antioxidant; free radical scavenging activity,doi_bioActivity
10.1016/j.jfca.2003.09.013,Antioxidant; free radical scavenging activity,doi_bioActivity
10.1016/j.jfca.2003.09.013,Antioxidant; free radical scavenging activity,doi_bioActivity
10.1016/j.jfca.2003.09.013,Antioxidant,doi_bioActivity
10.1016/j.jpba.2012.08.028,"cytotoxicity, antiangiogenic, antibacterial, trypanocidal, larvicidal against Aedes aegypti, trypanocidal against Trypanossoma cruzi, antinociceptive and anti-inflammatory, protective effect against cyclophosphamide-induced mutagenicity in mice",doi_bioActivity
10.1016/j.jpba.2012.08.028,Metabolite of (−)-grandisin formed during the biotransformation by rat liver microsomes,doi_bioActivity
10.1016/j.micres.2004.06.003,"{'M. luteus': 'The MIC values against M. luteus was 99 mg/mL.', 'S. aureus': 'The MIC values against S. aureus was 137 mg/mL.'}",doi_bioActivity
10.1016/j.phytochem.2005.04.043,Weak in vitro antifungal activity against Cladosporium sphaerospermum and Cladosporioides.,doi_bioActivity
10.1016/j.phytochem.2005.04.043,"Weak in vitro antifungal activity against Cladosporium sphaerospermum and Cladosporioides, induces cell proliferation: 70% on HeLa cells and 25% on CHO cells.",doi_bioActivity
10.1016/j.phytochem.2005.04.043,Not described.,doi_bioActivity
10.1016/j.phytochem.2005.04.043,No antifungal activity noted.,doi_bioActivity
10.1016/j.phytochem.2005.06.019,Inactive in DPPH free radical scavenging activity,doi_bioActivity
10.1016/j.phytochem.2005.06.019,Weak free radical scavenging activity towards DPPH,doi_bioActivity
10.1016/j.phytochem.2005.06.019,"Strong antioxidant activity, comparable with that of caffeic acid",doi_bioActivity
10.1016/j.phytochem.2005.06.019,"Strong antioxidant activity, comparable with that of caffeic acid",doi_bioActivity
10.1016/j.phytochem.2005.06.019,Weak free radical scavenging activities towards DPPH,doi_bioActivity
10.1016/j.phytochem.2007.08.012,potent trypanocidal activity against epimastigotes of Trypanosoma cruzi strain Y,doi_bioActivity
10.1016/j.phytochem.2007.08.012,potent trypanocidal activity against epimastigotes of Trypanosoma cruzi strain Y,doi_bioActivity
10.1016/j.phytochem.2007.08.012,potent trypanocidal activity against epimastigotes of Trypanosoma cruzi strain Y,doi_bioActivity
10.1016/j.phytochem.2007.08.012,most potent trypanocidal activity against epimastigotes of Trypanosoma cruzi strain Y among the isolated lignans,doi_bioActivity
10.1016/j.phytochem.2007.08.012,potent trypanocidal activity against epimastigotes of Trypanosoma cruzi strain Y,doi_bioActivity
10.1016/j.phytol.2010.11.003,Antifungal and acetylcholinesterase (AChE) inhibitory activities,doi_bioActivity
10.1016/j.phytol.2010.11.003,Antifungal and weak acetylcholinesterase (AChE) inhibitory activities,doi_bioActivity
10.1016/j.phytol.2010.11.003,Antifungal and weak acetylcholinesterase (AChE) inhibitory activities,doi_bioActivity
10.1016/j.phytol.2010.11.003,Antifungal and acetylcholinesterase (AChE) inhibitory activities,doi_bioActivity
10.1016/j.phytol.2010.11.003,Antifungal and weak acetylcholinesterase (AChE) inhibitory activities,doi_bioActivity
10.1016/j.phytol.2010.11.003,Antifungal and weak acetylcholinesterase (AChE) inhibitory activities,doi_bioActivity
10.1021/cc100076k,Inhibition of cathepsin V,doi_bioActivity
10.1021/cc100076k,Inhibition of cathepsin V,doi_bioActivity
10.1021/cc100076k,Inhibition of cathepsin V,doi_bioActivity
10.1021/cc100076k,Inhibition of cathepsin V,doi_bioActivity
10.1021/cc100076k,Inhibition of cathepsin V,doi_bioActivity
10.1021/cc100076k,Inhibition of cathepsin V,doi_bioActivity
10.1021/cc100076k,Inhibition of cathepsin V,doi_bioActivity
10.1021/cc100076k,Inhibition of cathepsin V,doi_bioActivity
10.1021/jf100233y,"Antioxidant, Antibacterial, Anti-inflammatory, Antimutagenic, Chemopreventive properties",doi_bioActivity
10.1021/jf100233y,More effective than gallic acid at inhibiting oral bacterial growth and the formation of Streptococcus mutans biofilms,doi_bioActivity
10.1021/jf100233y,"Inhibition of cell adhesion, alteration of cell redox status by depletion of both glutathione (GSH) and ATP",doi_bioActivity
10.1021/jf100233y,"More efficient than gallic acid as an inhibitor of the enzyme xanthine oxidase, endogenous source of superoxide anion, and of mitochondrial lipid peroxidation induced by FeIII-NADPH",doi_bioActivity
10.1021/jf100233y,Generates radicals that induce oxidative stress and hemolysis,doi_bioActivity
10.1021/jf60217a066,"Anesthetic properties, flavor similar to anise seed oil",doi_bioActivity
10.1021/jf60217a066,"Potent anesthetic, likely responsible for the pharmacological activity of plant infusions",doi_bioActivity
10.1021/np0103970,Weak inhibitory activity against trypomastigote forms of Trypanosoma cruzi,doi_bioActivity
10.1021/np0103970,Weak inhibitory activity against trypomastigote forms of Trypanosoma cruzi,doi_bioActivity
10.1021/np0103970,Inactive in brine shrimp lethality test,doi_bioActivity
10.1021/np0103970,Inactive in brine shrimp lethality test,doi_bioActivity
10.1021/np0103970,Inactive in brine shrimp lethality test,doi_bioActivity
10.1021/np030100t,Moderate free radical scavenging activity against DPPH as well as antioxidant activity evidenced by redox properties,doi_bioActivity
10.1021/np030100t,"Free radical scavenging activity, but less than that of Molecule_1 and Molecule_3",doi_bioActivity
10.1021/np030100t,"Moderate free radical scavenging activity against DPPH as well as antioxidant activity, similar to Molecule_1",doi_bioActivity
10.1021/np030100t,"Free radical scavenging activity, lower than Molecule_1 and Molecule_3",doi_bioActivity
10.1021/np030100t,"Free radical scavenging activity, similar to that of Molecule_2 and Molecule_6",doi_bioActivity
10.1021/np030100t,"Free radical scavenging activity, similar to that of Molecule_2 and Molecule_5",doi_bioActivity
10.1021/np0303963,DNA-damaging activity on mutant yeast strains of Saccharomyces cerevisiae,doi_bioActivity
10.1021/np0303963,Inactive on DNA-damaging activity assay,doi_bioActivity
10.1021/np0303963,Inactive on DNA-damaging activity assay,doi_bioActivity
10.1021/np0303963,DNA-damaging activity on mutant yeast strains of Saccharomyces cerevisiae,doi_bioActivity
10.1021/np030530j,Antifungal activity against Cladosporium cladosporioides and C. sphaerospermum with high potential as antifungal compounds,doi_bioActivity
10.1021/np030530j,Antifungal activity against Cladosporium cladosporioides and C. sphaerospermum,doi_bioActivity
10.1021/np030530j,Antifungal activity against Cladosporium cladosporioides and C. sphaerospermum,doi_bioActivity
10.1021/np030530j,Antifungal activity against Cladosporium cladosporioides and C. sphaerospermum,doi_bioActivity
10.1021/np049863m,Strong antioxidant activity; moderate inhibitory activity against acetylcholinesterase (AchE) at 0.1 μM concentration in TLC screening,doi_bioActivity
10.1021/np049863m,Antioxidant activity,doi_bioActivity
10.1021/np049863m,Strong free-radical scavenging activity,doi_bioActivity
10.1021/np049863m,Antioxidant activity,doi_bioActivity
10.1021/np049863m,Antioxidant activity,doi_bioActivity
10.1021/np049863m,Antioxidant activity,doi_bioActivity
10.1021/np049863m,"Moderate acetylcholinesterase inhibitors at a concentration of 0.1 μM, Moderate activity (IC50 1.86 μM) in vitro rat brain assay",doi_bioActivity
10.1021/np049863m,Moderate acetylcholinesterase inhibitors at a concentration of 1.0 μM in TLC screening,doi_bioActivity
10.1021/np049863m,Antioxidant activity,doi_bioActivity
10.1021/np070312g,"Moderate antioxidant activities (40–70% at 100 ppm), moderate inhibition of COX-1 (ca. 40%) and marginal inhibition of COX-2 enzymes (<10% at 100 ppm)",doi_bioActivity
10.1021/np070312g,"Moderate antioxidant activity (compared to standard reference compounds), moderate inhibition of lipoperoxidation and COX-1 enzyme (75% and 40% respectively at 100 ppm)",doi_bioActivity
10.1021/np070312g,"Moderate antioxidant activity (compared to standard reference compounds), moderate inhibition of lipoperoxidation and COX-1 enzyme (75% and 58% respectively at 100 ppm)",doi_bioActivity
10.1021/np070312g,"Moderate antioxidant activities (40–70% at 100 ppm), moderate inhibition of COX-1 (ca. 40%) and marginal inhibition of COX-2 enzymes (<10% at 100 ppm)",doi_bioActivity
10.1021/np070312g,"Moderate antioxidant activity (compared to standard reference compounds), moderate inhibition of lipoperoxidation and COX-1 enzyme (75% and 40% respectively at 100 ppm)",doi_bioActivity
10.1021/np070312g,"Moderate antioxidant activity (compared to standard reference compounds), moderate inhibition of lipoperoxidation and COX-1 enzyme (75% and 58% respectively at 100 ppm)",doi_bioActivity
10.1021/np1007476,"Antioxidant activity, with an IC50 value of 7.50 μM against DPPH free radical scavenging.",doi_bioActivity
10.1021/np1007476,"Antioxidant activity, with an IC50 value of 18.60 μM against DPPH free radical scavenging.",doi_bioActivity
10.1021/np1007476,"Antioxidant activity, with an IC50 value of 18.50 μM against DPPH free radical scavenging.",doi_bioActivity
10.1021/np100840w,Cytotoxicity against human melanoma (MDA/MB-435) and human glioblastoma (SF-295) cells with IC50 values of 0.36 μM,doi_bioActivity
10.1021/np100840w,Cytotoxicity against human cancer cell lines with less potency compared to Molecule_1,doi_bioActivity
10.1021/np100840w,Cytotoxicity not significant; IC50 values >5 μM,doi_bioActivity
10.1021/np100840w,Cytotoxicity against human cancer cell lines with nearly similar potency to Molecule_1,doi_bioActivity
10.1021/np100840w,Decreased cytotoxicity compared to non-acetylated molecules; IC50 values >5 μM,doi_bioActivity
10.1021/np100840w,Decreased cytotoxicity compared to non-acetylated molecules; IC50 values >5 μM,doi_bioActivity
10.1021/np50086a012,Moderate molluscicidal activity against the aquatic snail Biomphalaria glabrata with LC50 of 5 ppm; moderate cytotoxic activity against HeLa epithelioid carcinoma cells with IC50 of 2.5 µg/ml and against BT-20 human breast carcinoma cells,doi_bioActivity
10.1021/np50086a012,Moderate molluscicidal activity against the aquatic snail Biomphalaria glabrata with LC50 of 20 ppm; moderate cytotoxic activity against HeLa epithelioid carcinoma cells with IC50 of 8.5 µg/ml and against BT-20 human breast carcinoma cells,doi_bioActivity
10.1021/np50086a012,Moderate molluscicidal activity against the aquatic snail Biomphalaria glabrata with LC50 of 5 ppm; moderate cytotoxic activity against HeLa epithelioid carcinoma cells with IC50 of 2.5 µg/ml and against BT-20 human breast carcinoma cells,doi_bioActivity
10.1021/np50086a012,Moderate molluscicidal activity against the aquatic snail Biomphalaria glabrata with LC50 of 20 ppm; moderate cytotoxic activity against HeLa epithelioid carcinoma cells with IC50 of 8.5 µg/ml and against BT-20 human breast carcinoma cells,doi_bioActivity
10.1021/np800612x,"Not specifically mentioned, inactive for tested cell lines at given concentrations",doi_bioActivity
10.1021/np800612x,Cytotoxic activity against human cancer cell lines HL-60 (human myeloblastic leukemia) and SF-295 (human glioblastoma),doi_bioActivity
10.1021/np800612x,"Not specifically mentioned, inactive for tested cell lines at given concentrations",doi_bioActivity
10.1021/np800612x,"Not specifically mentioned, inactive for tested cell lines at given concentrations",doi_bioActivity
10.1021/np800612x,"Precursor for the design of metformin and other biguanide-type hypoglycemic drugs, inactive for tested cell lines at given concentrations",doi_bioActivity
10.1021/np800612x,"Not specifically mentioned, inactive for tested cell lines at given concentrations",doi_bioActivity
10.1021/np800612x,Cytotoxic activity against human cancer cell lines HL-60 (human myeloblastic leukemia) and SF-295 (human glioblastoma),doi_bioActivity
10.1021/np800612x,"Not specifically mentioned, inactive for tested cell lines at given concentrations",doi_bioActivity
10.1021/np800612x,"Not specifically mentioned, inactive for tested cell lines at given concentrations",doi_bioActivity
10.1021/np800612x,"Precursor for the design of metformin and other biguanide-type hypoglycemic drugs, inactive for tested cell lines at given concentrations",doi_bioActivity
10.1021/np9004079,"Cytotoxic activity against human tumor cell lines; however, IC50 values were >5 µM indicating low or no activity in the tests carried out.",doi_bioActivity
10.1021/np9004079,"Not explicitly tested in the provided document, but similar cytotoxicity could be inferred as it's structurally related to Molecule_1.",doi_bioActivity
10.1021/np9004079,"Significant cytotoxicity against four cancer cell lines (HL-60, HCT-8, MDA/MB-435, and SF-295), with IC50 values ranging from 0.13 to 1.0 µM",doi_bioActivity
10.1021/np9004079,"Significant cytotoxicity against human tumor cell lines as part of a mixture with Molecule_3, with similar IC50 values.",doi_bioActivity
10.1021/np9004079,"Cytotoxic activity against human tumor cell lines; however, IC50 values were >5 µM indicating low or no activity in the tests carried out.",doi_bioActivity
10.1021/np9704617,Moderate antifungal activity against Cladosporium cladosporioides,doi_bioActivity
10.1021/np9704617,"Previously obtained from enzymatic hydrolysis, reported for the first time as a natural product",doi_bioActivity
10.1055/s-0029-1185364,Trypanocidal activity with IC50 of 27.0 µM,doi_bioActivity
10.1055/s-0029-1185364,"Weak trypanocidal activity, IC50 of 678.2 µM",doi_bioActivity
10.1055/s-0029-1185364,"Weak trypanocidal activity, IC50 of 93.5 µM",doi_bioActivity
10.1055/s-0029-1185364,"Weak trypanocidal activity, IC50 of 289.1 µM",doi_bioActivity
10.1055/s-0029-1185364,"Weak trypanocidal activity, IC50 of 620.1 µM",doi_bioActivity
10.1055/s-0029-1185364,"Potent trypanocidal activity, IC50 of 3.1 µM",doi_bioActivity
10.1055/s-0029-1185364,"Trypanocidal activity, IC50 of 47.5 µM",doi_bioActivity
10.1055/s-0034-1368301,"Cytotoxicity against HL-60 promyelocytic leukemia cells with growth inhibition effect by G2/M cell cycle arrest, reduction of tubulin alpha and beta isomers and 14-3-3 protein gamma expression, followed by a decrease of apoptotic and inflammatory proteins, leading to mitochondrial oxidative damage and autophagy-associated cell death.",doi_bioActivity
10.1055/s-0034-1368301,"Inhibits DNA synthesis by inhibition of DNA polymerase α and δ, causing cytotoxicity, S-phase arrest, apoptosis in HL-60 promyelocytic leukemia cells, influences microtubule dynamics, modulates proteasome activator complex expression, controls the inflammatory cascade, and leads to characteristics of autophagy- or oncosis-like cell death.",doi_bioActivity
10.1080/14786410412331271979,Cytotoxic activity against C6 (rat glioma) cell lines (IC50=3.2 mg/mL) and Hep-2 (larynx epidermoid carcinoma) cell lines (IC50=3.6 mg/mL),doi_bioActivity
10.1080/14786410412331271979,Cytotoxic activity against C6 (IC50=4.9 mg/mL) and HeLa (human cervix carcinoma) cell lines (IC50=5.3 mg/mL),doi_bioActivity
10.1080/14786410412331271979,"Moderate cytotoxic activity against C6, Hep-2, and HeLa cell lines.",doi_bioActivity
10.1080/14786410802243271,Inhibition of epimastigote forms of Trypanosoma cruzi with IC50 value of 15.8 mg/mL,doi_bioActivity
10.1080/14786410802243271,Inhibition of epimastigote forms of Trypanosoma cruzi with IC50 value of 16.3 mg/mL,doi_bioActivity
10.1080/14786410802243271,Inhibition of epimastigote forms of Trypanosoma cruzi with IC50 value of 6.1 mg/mL,doi_bioActivity
10.1080/14786410802243271,Weak inhibition of epimastigote forms of Trypanosoma cruzi with IC50 value of 119.6 mg/mL,doi_bioActivity
10.1080/14786410802243271,Weak inhibition of epimastigote forms of Trypanosoma cruzi with IC50 value of 111.7 mg/mL,doi_bioActivity
10.1080/14786410903335232,"Inhibition of TNF-α induced NF-κB activity; anti-microbial, antioxidant, and cytotoxic properties",doi_bioActivity
10.1080/14786410903335232,Inhibition of TNF-α induced NF-κB activity; greater inhibitory activity than gallic acid,doi_bioActivity
10.1080/14786410903335232,Inhibition of TNF-α induced NF-κB activity,doi_bioActivity
10.1080/14786410903335232,Inhibition of TNF-α induced NF-κB activity,doi_bioActivity
10.1080/14786410903335232,Inhibition of TNF-α induced NF-κB activity,doi_bioActivity
10.1080/14786410903335232,Inhibition of TNF-α induced NF-κB activity; most cytotoxic compound evaluated,doi_bioActivity
10.1080/14786410903335232,Inhibition of TNF-α induced NF-κB activity,doi_bioActivity
10.1080/14786410903335232,Inhibition of TNF-α induced NF-κB activity,doi_bioActivity
10.1080/14786410903335232,Inhibition of TNF-α induced NF-κB activity,doi_bioActivity
10.1080/14786419.2011.647020,anti-allergic activity,doi_bioActivity
10.1093/mutage/gep034,Genotoxic and mutagenic at highest concentration; chemoprotective at low concentrations,doi_bioActivity
10.1093/mutage/gep034,"Presence suggested, not clearly described",doi_bioActivity
10.1093/mutage/gep034,Genotoxic and mutagenic at highest concentration; chemoprotective at low concentrations,doi_bioActivity
10.1093/mutage/gep034,"Presence suggested, not clearly described",doi_bioActivity
10.1093/mutage/gep034,Genotoxic and mutagenic at highest concentration; chemoprotective at low concentrations,doi_bioActivity
10.1093/mutage/gep034,"Presence suggested, not clearly described",doi_bioActivity
10.1107/S1600536803019913,Inhibitor of adenine phosphoribosyltransferase (APRT) enzyme from Leishmania,doi_bioActivity
10.1107/S160053680302107X,Inhibition of adenine phosphoribosyltransferase (APRT) enzyme activity from Leishmania tarentolae,doi_bioActivity
10.1248/bpb.31.538,Trypanocidal agent with IC50 value of 33.8 mM,doi_bioActivity
10.1248/bpb.31.538,Trypanocidal agent with IC50 value of 558.3 mM,doi_bioActivity
10.1248/bpb.31.538,Trypanocidal agent with IC50 value of 190.1 mM,doi_bioActivity
10.1248/bpb.31.538,Trypanocidal agent with IC50 value of 44.8 mM,doi_bioActivity
10.1248/bpb.31.538,Trypanocidal agent with IC50 value of 33.2 mM,doi_bioActivity
10.1248/bpb.31.538,"Trypanocidal agent with IC50 value of 2.82 mM, nearly four times more potent than benznidazole",doi_bioActivity
10.1248/bpb.31.538,Trypanocidal agent with IC50 value of 230.7 mM,doi_bioActivity
10.1248/bpb.31.538,Trypanocidal agent with IC50 value of 22.5 mM,doi_bioActivity
10.1248/bpb.31.538,Trypanocidal agent with IC50 value of 128.5 mM,doi_bioActivity
10.1248/cpb.56.407,"Antinociceptive, semi-synthetic piperidine alkaloid derivatives showing central analgesic activity.",doi_bioActivity
10.1248/cpb.56.407,"Significant antinociceptive activity by inhibiting acetic acid-induced abdominal constrictions with 37% of inhibition, no activity shown in the carrageenan-induced rat paw edema test for anti-inflammatory activity at the dose used.",doi_bioActivity
10.1248/cpb.56.407,"Antinociceptive and anti-inflammatory, inhibited carrageenan-induced rat paw edema with an ED50 value of 56.6 mmol/kg, also acted as a peripheral analgesic.",doi_bioActivity
10.1248/cpb.56.407,"Significant antinociceptive activity, notably in the formalin-induced pain test during the inflammatory phase, suggesting central analgesic activity without anti-inflammatory effects at the tested dose.",doi_bioActivity
10.1248/cpb.56.407,"Series of 2,3,6-trisubstituted piperidine alkaloids showing varying levels of antinociceptive activity.",doi_bioActivity
10.1248/cpb.56.407,"Antinociceptive, semi-synthetic piperidine alkaloid derivatives showing central analgesic activity.",doi_bioActivity
10.1248/cpb.56.407,"Significant antinociceptive activity by inhibiting acetic acid-induced abdominal constrictions with 37% of inhibition, no activity shown in the carrageenan-induced rat paw edema test for anti-inflammatory activity at the dose used.",doi_bioActivity
10.1248/cpb.56.407,"Antinociceptive and anti-inflammatory, inhibited carrageenan-induced rat paw edema with an ED50 value of 56.6 mmol/kg, also acted as a peripheral analgesic.",doi_bioActivity
10.1248/cpb.56.407,"Significant antinociceptive activity, notably in the formalin-induced pain test during the inflammatory phase, suggesting central analgesic activity without anti-inflammatory effects at the tested dose.",doi_bioActivity
10.1248/cpb.56.407,"Series of 2,3,6-trisubstituted piperidine alkaloids showing varying levels of antinociceptive activity.",doi_bioActivity
10.1515/znc-2002-5-602,Exhibited activity against insects and potential anticarcinogenic activity including use against tumors like skin cancer,doi_bioActivity
10.1515/znc-2002-5-602,Exhibited activity against insects and potential anticarcinogenic activity,doi_bioActivity
10.1515/znc-2002-5-602,Exhibited activity against insects and potential anticarcinogenic activity,doi_bioActivity
10.1515/znc-2002-5-602,Exhibited activity against insects and potential anticarcinogenic activity including use against tumors like skin cancer,doi_bioActivity
10.1515/znc-2002-5-602,Exhibited activity against insects and potential anticarcinogenic activity,doi_bioActivity
10.1515/znc-2002-5-602,Exhibited activity against insects and potential anticarcinogenic activity,doi_bioActivity
10.1515/znc-2002-5-602,Exhibited activity against insects and potential anticarcinogenic activity including use against tumors like skin cancer,doi_bioActivity
10.1515/znc-2002-5-602,Exhibited activity against insects and potential anticarcinogenic activity,doi_bioActivity
10.1515/znc-2002-5-602,Exhibited activity against insects and potential anticarcinogenic activity,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of glycosomal glyceraldehyde-3-phosphate dehydrogenase (gGAPDH),doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of gGAPDH and trypanocidal activity,doi_bioActivity
10.1515/znc-2008-5-611,Limited trypanocidal activity; not tested for enzyme inhibition,doi_bioActivity
10.1515/znc-2008-5-611,Not established in this document,doi_bioActivity
10.1515/znc-2008-5-611,Not tested for enzyme inhibition or trypanocidal activity,doi_bioActivity
10.1515/znc-2008-5-611,Not tested for enzyme inhibition or trypanocidal activity,doi_bioActivity
10.1515/znc-2008-5-611,Limited trypanocidal activity; not tested for enzyme inhibition,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of APRT,doi_bioActivity
10.1515/znc-2008-5-611,Trypanocidal activity against T. cruzi,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of T. cruzi trypomastigote lysis,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of TR and strong inhibitory activity on gGAPDH,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of TR and strong inhibitory activity on gGAPDH,doi_bioActivity
10.1515/znc-2008-5-611,Not tested for enzyme inhibition or trypanocidal activity,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of gGAPDH and APRT,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of gGAPDH and APRT,doi_bioActivity
10.1515/znc-2008-5-611,"Inhibition of gGAPDH, APRT, and trypanocidal activity",doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of gGAPDH and APRT,doi_bioActivity
10.1515/znc-2008-5-611,Limited trypanocidal activity; not tested for enzyme inhibition,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of gGAPDH and APRT,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of gGAPDH and APRT,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of gGAPDH and APRT,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of gGAPDH and APRT,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of gGAPDH and APRT,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of gGAPDH,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of gGAPDH and APRT,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of gGAPDH and APRT,doi_bioActivity
10.1515/znc-2008-5-611,Not tested for enzyme inhibition or trypanocidal activity,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of glycosomal glyceraldehyde-3-phosphate dehydrogenase (gGAPDH),doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of gGAPDH and trypanocidal activity,doi_bioActivity
10.1515/znc-2008-5-611,Limited trypanocidal activity; not tested for enzyme inhibition,doi_bioActivity
10.1515/znc-2008-5-611,Not established in this document,doi_bioActivity
10.1515/znc-2008-5-611,Not tested for enzyme inhibition or trypanocidal activity,doi_bioActivity
10.1515/znc-2008-5-611,Not tested for enzyme inhibition or trypanocidal activity,doi_bioActivity
10.1515/znc-2008-5-611,Limited trypanocidal activity; not tested for enzyme inhibition,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of APRT,doi_bioActivity
10.1515/znc-2008-5-611,Trypanocidal activity against T. cruzi,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of T. cruzi trypomastigote lysis,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of TR and strong inhibitory activity on gGAPDH,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of TR and strong inhibitory activity on gGAPDH,doi_bioActivity
10.1515/znc-2008-5-611,Not tested for enzyme inhibition or trypanocidal activity,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of gGAPDH and APRT,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of gGAPDH and APRT,doi_bioActivity
10.1515/znc-2008-5-611,"Inhibition of gGAPDH, APRT, and trypanocidal activity",doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of gGAPDH and APRT,doi_bioActivity
10.1515/znc-2008-5-611,Limited trypanocidal activity; not tested for enzyme inhibition,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of gGAPDH and APRT,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of gGAPDH and APRT,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of gGAPDH and APRT,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of gGAPDH and APRT,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of gGAPDH and APRT,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of gGAPDH,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of gGAPDH and APRT,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of gGAPDH and APRT,doi_bioActivity
10.1515/znc-2008-5-611,Not tested for enzyme inhibition or trypanocidal activity,doi_bioActivity
10.1515/znc-2009-11-1212,Antifungal activity and moderate Acetylcholinesterase (AChE) inhibitory activity,doi_bioActivity
10.1515/znc-2009-11-1212,Potent Acetylcholinesterase (AChE) inhibitory activity,doi_bioActivity
10.1515/znc-2009-11-1212,Weak Acetylcholinesterase (AChE) inhibitory activity,doi_bioActivity
10.1515/znc-2009-11-1212,Potent antifungal activity and moderate Acetylcholinesterase (AChE) inhibitory activity,doi_bioActivity
10.1515/znc-2009-11-1212,"Moderate antifungal activity, not active as Acetylcholinesterase (AChE) inhibitor",doi_bioActivity
10.1515/znc-2009-11-1212,"Weak antifungal activity, not active as Acetylcholinesterase (AChE) inhibitor",doi_bioActivity
10.1515/znc-2009-11-1212,Antifungal activity and moderate Acetylcholinesterase (AChE) inhibitory activity,doi_bioActivity
10.1515/znc-2009-11-1212,Potent Acetylcholinesterase (AChE) inhibitory activity,doi_bioActivity
10.1515/znc-2009-11-1212,Weak Acetylcholinesterase (AChE) inhibitory activity,doi_bioActivity
10.1515/znc-2009-11-1212,Potent antifungal activity and moderate Acetylcholinesterase (AChE) inhibitory activity,doi_bioActivity
10.1515/znc-2009-11-1212,"Moderate antifungal activity, not active as Acetylcholinesterase (AChE) inhibitor",doi_bioActivity
10.1515/znc-2009-11-1212,"Weak antifungal activity, not active as Acetylcholinesterase (AChE) inhibitor",doi_bioActivity
10.1590/S0073-47212009000100009,"Toxicity; Ingestion and topical application tests showed significant mortality rates in worker bees and larvae of Apis mellifera and Scaptotrigona postica, with observable symptoms of intoxication such as sluggish movement, disorientation, leg trembling, paralysis, and eventual death.",doi_bioActivity
10.1590/S0100-40422005000400009,Antifungal activity (moderate activity against Cladosporium cladosporioides),doi_bioActivity
10.1590/S0100-40422005000400009,"Antifungal activity (moderate activity against Cladosporium cladosporioides; New compound, not previously described in literature)",doi_bioActivity
10.1590/S0100-40422005000400009,Antifungal activity (no activity alone but mixture with Molecule 4 shows activity),doi_bioActivity
10.1590/S0100-40422005000400009,Antifungal activity (part of the activity attributed to mixture with Molecule 3 against Cladosporium cladosporioides),doi_bioActivity
10.1590/S0100-40422005000400009,Antifungal activity not tested,doi_bioActivity
10.1590/S0100-40422005000600011,Active against Cladosporium cladosporioides and Cladosporium sphaerospermum (antifungal),doi_bioActivity
10.1590/S0100-40422005000600011,Active against Cladosporium cladosporioides and Cladosporium sphaerospermum (antifungal),doi_bioActivity
10.1590/S0100-40422005000600011,"Known as a powerful antifungal agent used commercially, but no antifungal activity reported in this specific test against Cladosporium cladosporioides and Cladosporium sphaerospermum",doi_bioActivity
10.1590/S0100-40422006000300016,antioxidant activity,doi_bioActivity
10.1590/S0100-40422006000300016,antioxidant activity,doi_bioActivity
10.1590/S0100-40422006000300016,antioxidant activity,doi_bioActivity
10.1590/S0100-40422006000300016,antioxidant activity,doi_bioActivity
10.1590/S0100-40422006000300016,antioxidant activity,doi_bioActivity
10.1590/S0100-40422006000300016,antioxidant activity,doi_bioActivity
10.1590/S0100-40422008000400005,Moderate Trypanocidal Activity (IC50 136.9 µM),doi_bioActivity
10.1590/S0100-40422008000400005,Moderate Trypanocidal Activity (IC50 144.9 µM),doi_bioActivity
10.1590/S0100-40422008000400023,Moderate antifungal activity (MIC 100.0 µg/mL),doi_bioActivity
10.1590/S0100-40422008000400023,Moderate antifungal activity (MIC 100.0 µg/mL),doi_bioActivity
10.1590/S0100-40422008000400023,Weak antifungal activity (MIC 200.0 µg/mL),doi_bioActivity
10.1590/S0100-40422008000400023,Inactive,doi_bioActivity
10.1590/S0100-40422010000900005,Insecticidal activity against Spodoptera frugiperda,doi_bioActivity
10.1590/S0100-40422010001000006,In vitro cytotoxicity against HeLa (cervix tumor human cell line); weak activity against Cladosporium cladosporioides and C. sphaerospermum at 100 μg/mL; no activity against Saccharomyces cerevisiae mutant strains RS 321,doi_bioActivity
10.1590/S0100-40422010001000006,In vitro cytotoxicity against HeLa cell line; no significant antifungal activity described; no mutagenic activity against S. cerevisiae mutant strains,doi_bioActivity
10.1590/S0100-40422010001000006,In vitro cytotoxicity against HeLa cell line; no significant antifungal activity described; no mutagenic activity against S. cerevisiae mutant strains,doi_bioActivity
10.1590/S0100-40422010001000006,In vitro cytotoxicity against HeLa cell line; no significant antifungal activity described; no mutagenic activity against S. cerevisiae mutant strains,doi_bioActivity
10.1590/S0100-40422010001000006,Weak activity against Cladosporium cladosporioides and C. sphaerospermum at 100 μg/mL; in vitro cytotoxicity against HeLa cell line; no mutagenic activity against S. cerevisiae mutant strains,doi_bioActivity
10.1590/S0100-40422010001000006,In vitro cytotoxicity against HeLa cell line; no significant antifungal activity described; no mutagenic activity against S. cerevisiae mutant strains,doi_bioActivity
10.1590/S0100-40422010001000006,In vitro cytotoxicity against HeLa (cervix tumor human cell line); weak activity against Cladosporium cladosporioides and C. sphaerospermum at 100 μg/mL; no activity against Saccharomyces cerevisiae mutant strains RS 321,doi_bioActivity
10.1590/S0100-40422010001000006,In vitro cytotoxicity against HeLa cell line; no significant antifungal activity described; no mutagenic activity against S. cerevisiae mutant strains,doi_bioActivity
10.1590/S0100-40422010001000006,In vitro cytotoxicity against HeLa cell line; no significant antifungal activity described; no mutagenic activity against S. cerevisiae mutant strains,doi_bioActivity
10.1590/S0100-40422010001000006,In vitro cytotoxicity against HeLa cell line; no significant antifungal activity described; no mutagenic activity against S. cerevisiae mutant strains,doi_bioActivity
10.1590/S0100-40422010001000006,Weak activity against Cladosporium cladosporioides and C. sphaerospermum at 100 μg/mL; in vitro cytotoxicity against HeLa cell line; no mutagenic activity against S. cerevisiae mutant strains,doi_bioActivity
10.1590/S0100-40422010001000006,In vitro cytotoxicity against HeLa cell line; no significant antifungal activity described; no mutagenic activity against S. cerevisiae mutant strains,doi_bioActivity
10.1590/S0102-695X2007000300003,Weak antibacterial activity against Gram-positive bacteria S. aureus and B. subtilis. Weak scavenging activity with IC50 of 50.0 µM against DPPH free radical.,doi_bioActivity
10.1590/S0102-695X2007000300003,Weak antibacterial activity against Gram-positive bacteria S. aureus and B. subtilis. Weak scavenging activity with IC50 of 40.7 µM against DPPH free radical.,doi_bioActivity
10.1590/S0102-695X2007000300003,Weak antibacterial activity against Gram-positive bacteria S. aureus and B. subtilis. Weak scavenging activity with IC50 of 35.4 µM against DPPH free radical.,doi_bioActivity
10.1590/S0102-695X2007000300003,Weak antibacterial activity against Gram-positive bacteria S. aureus and B. subtilis. Moderate scavenging activity with IC50 of 18.5 µM against DPPH free radical.,doi_bioActivity
10.1590/S0102-695X2009000100002,Low inhibitory activity against T. cruzi gGAPDH enzyme,doi_bioActivity
10.1590/S0102-695X2009000100002,High inhibitory activity against T. cruzi gGAPDH enzyme,doi_bioActivity
10.1590/S0102-695X2009000100002,Complete inhibition of T. cruzi gGAPDH enzyme at 268.8 mmol/L,doi_bioActivity
10.1590/S0102-695X2010000100002,Weak trypanocidal activity,doi_bioActivity
10.1590/S0102-695X2010000100002,Weak trypanocidal activity,doi_bioActivity
10.1590/S0102-695X2010000100002,Moderate trypanocidal activity,doi_bioActivity
10.1590/S0102-695X2010000100002,Moderate trypanocidal activity,doi_bioActivity
10.1590/S0102-695X2010000100002,Moderate trypanocidal activity,doi_bioActivity
10.1590/S0102-695X2010000100002,Moderate trypanocidal activity,doi_bioActivity
10.1590/S0102-695X2010000100002,Weak trypanocidal activity,doi_bioActivity
10.1590/S0102-695X2010000100002,Weak trypanocidal activity,doi_bioActivity
10.1590/S0102-695X2012005000106,Cytotoxic activity against human cancer cell lines; selective cytotoxicity against oral carcinoma and breast cancer cell lines,doi_bioActivity
10.1590/S0102-695X2012005000106,"Cytotoxic activity against different cancer cell lines; Leishmanicidal activity against Leishmania braziliensis; Reported activity against other cancer lines, HIV1 virus, and bacterial strains",doi_bioActivity
10.1590/S0102-695X2012005000106,Cytotoxic activity against human cancer cell lines; selective cytotoxicity against oral carcinoma and breast cancer cell lines,doi_bioActivity
10.1590/S0102-695X2012005000106,"Cytotoxic activity against different cancer cell lines; Leishmanicidal activity against Leishmania braziliensis; Reported activity against other cancer lines, HIV1 virus, and bacterial strains",doi_bioActivity
10.1590/S0103-50532003000500012,Antioxidant activity,doi_bioActivity
10.1590/S0103-50532003000500012,Antioxidant activity,doi_bioActivity
10.1590/S0103-50532003000500012,Antioxidant activity,doi_bioActivity
10.1590/S0103-50532005000300018,Moderate trypanocidal activity,doi_bioActivity
10.1590/S0103-50532005000300018,Moderate trypanocidal activity,doi_bioActivity
10.1590/S0103-50532005000400005,Poor radical scavenger due to absence of phenolic hydroxyls,doi_bioActivity
10.1590/S0103-50532005000400005,Poor radical scavenger,doi_bioActivity
10.1590/S0103-50532005000400005,Poor radical scavenger,doi_bioActivity
10.1590/S0103-50532005000400005,Free radical scavenger (ΔA 32% at 50 µmol L-1),doi_bioActivity
10.1590/S0103-50532005000400005,Strong radical scavenger (ΔA 73% at 50 µmol L-1),doi_bioActivity
10.1590/S0103-50532005000400005,Free radical scavenger (ΔA 16% at 50 µmol L-1),doi_bioActivity
10.1590/S0103-50532005000800008,Strong antioxidative properties,doi_bioActivity
10.1590/S0103-50532005000800008,Strong antioxidant activity,doi_bioActivity
10.1590/S0103-50532005000800008,Antioxidant activity,doi_bioActivity
10.1590/S0103-50532005000800008,Antioxidant activity,doi_bioActivity
10.1590/S0103-50532005000800008,Strong antioxidant activity,doi_bioActivity
10.1590/S0103-50532005000800008,Strong antioxidant activity,doi_bioActivity
10.1590/S0103-50532005000800008,Antioxidant activity,doi_bioActivity
10.1590/S0103-50532005000800008,Antioxidant activity,doi_bioActivity
10.1590/S0103-50532005000800008,Antioxidant activity,doi_bioActivity
10.1590/S0103-50532005000800008,Strong antioxidant activity,doi_bioActivity
10.1590/S0103-50532005000800008,Very strong antioxidant activity,doi_bioActivity
10.1590/S0103-50532005000800026,insignificant antimicrobial activity against Staphylococcus aureus and Micrococcus luteus at 2.9 mmol L-1 concentration,doi_bioActivity
10.1590/S0103-50532005000800026,insignificant antimicrobial activity against Staphylococcus aureus and Micrococcus luteus at 2.9 mmol L-1 concentration,doi_bioActivity
10.1590/S0103-50532005000800026,insignificant antimicrobial activity against Staphylococcus aureus and Micrococcus luteus at 2.9 mmol L-1 concentration,doi_bioActivity
10.1590/S0103-50532005000800026,insignificant antimicrobial activity against Staphylococcus aureus and Micrococcus luteus at 2.9 mmol L-1 concentration,doi_bioActivity
10.1590/S0103-50532005000800026,insignificant antimicrobial activity against Staphylococcus aureus and Micrococcus luteus at 2.9 mmol L-1 concentration,doi_bioActivity
10.1590/S0103-50532005000800026,insignificant antimicrobial activity against Staphylococcus aureus and Micrococcus luteus at 2.9 mmol L-1 concentration,doi_bioActivity
10.1590/S0103-50532005000800026,insignificant antimicrobial activity against Staphylococcus aureus and Micrococcus luteus at 2.9 mmol L-1 concentration,doi_bioActivity
10.1590/S0103-50532005000800029,"Antifungal activity against Cladosporium cladosporioides and C. sphaerospermum, and cytotoxicity against human cervical tumor cell line (HeLa) in vitro",doi_bioActivity
10.1590/S0103-50532005000800029,"Antifungal activity against Cladosporium cladosporioides and C. sphaerospermum, weak cytotoxicity against human cervical tumor cell line (HeLa) in vitro",doi_bioActivity
10.1590/S0103-50532005000800029,Strong cytotoxicity against human cervical tumor cell line (HeLa) in vitro,doi_bioActivity
10.1590/S0103-50532005000800029,"Antifungal activity against Cladosporium cladosporioides and C. sphaerospermum, and cytotoxicity against human cervical tumor cell line (HeLa) in vitro",doi_bioActivity
10.1590/S0103-50532005000800029,"Antifungal activity against Cladosporium cladosporioides and C. sphaerospermum, weak cytotoxicity against human cervical tumor cell line (HeLa) in vitro",doi_bioActivity
10.1590/S0103-50532005000800029,Strong cytotoxicity against human cervical tumor cell line (HeLa) in vitro,doi_bioActivity
10.1590/S0103-50532006000300017,Moderate insecticidal activities against Atta sexdens rubropilosa workers,doi_bioActivity
10.1590/S0103-50532006000300017,Moderate insecticidal activities against Atta sexdens rubropilosa workers,doi_bioActivity
10.1590/S0103-50532006000300017,Moderate insecticidal activities against Atta sexdens rubropilosa workers,doi_bioActivity
10.1590/S0103-50532006000300017,Moderate insecticidal activities against Atta sexdens rubropilosa workers,doi_bioActivity
10.1590/S0103-50532006000300017,Moderate insecticidal activities against Atta sexdens rubropilosa workers,doi_bioActivity
10.1590/S0103-50532007000700017,"Antifungal activity, moderate activity with MIC of 100 μg compared to standard nystatin with 1.0 μg",doi_bioActivity
10.1590/S0103-50532007000700017,"Antifungal activity, moderate activity with MIC of 100 μg compared to standard nystatin with 1.0 μg",doi_bioActivity
10.1590/S0103-50532009000100029,Trypanocidal activity with IC50 of 9.8 µmol L-1 against Trypanosoma cruzi,doi_bioActivity
10.1590/S0103-50532009000100029,Trypanocidal activity with IC50 of 3.7 µmol L-1 against Trypanosoma cruzi,doi_bioActivity
10.1590/S0103-50532009000400008,"{'P_falciparum': 'IC50 2.6 ± 0.4 µM', 'T_b_rhodesiense': 'IC50 9.6 ± 1.1 µM', 'L_donovani': 'Inactive', 'KB_cells': 'IC50 19.8 ± 3.7 µM'}",doi_bioActivity
10.1590/S0103-50532009000400008,"{'P_falciparum': 'IC50 3.0 ± 0.2 µM', 'T_b_rhodesiense': 'IC50 4.3 ± 0.9 µM', 'L_donovani': 'Inactive', 'KB_cells': 'IC50 > 100 µM'}",doi_bioActivity
10.1590/S0103-50532009000400008,"{'P_falciparum': 'IC50 11.6 ± 1.2 µM', 'T_b_rhodesiense': 'IC50 28.5 ± 2.9 µM', 'L_donovani': 'Inactive', 'KB_cells': 'IC50 80.7 ± 6.8 µM'}",doi_bioActivity
10.1590/S0103-50532010000500016,Insecticidal and Fungicidal,doi_bioActivity
10.1590/S0103-50532010000500016,"Insecticidal and Fungicidal, weak activity in ants ingestion assay",doi_bioActivity
10.1590/S0103-50532010000500016,"Insecticidal and Fungicidal, though not toxic to the leaf-cutting ants",doi_bioActivity
10.1590/S0103-50532010000500016,Toxicity against leaf-cutting ants,doi_bioActivity
10.1590/S0103-50532010000500016,"Potentially active compound against A. sexdens rubropilosa, significant ant mortality",doi_bioActivity
10.1590/S0103-50532010000500016,Toxicity against leaf-cutting ants,doi_bioActivity
10.1590/S1519-566X2008000600013,"Increase in larval mortality, elongation of larval development time, and reduction in larval survival",doi_bioActivity
10.1590/S1519-566X2008000600013,Less effective than other compounds against T. absoluta,doi_bioActivity
10.1590/S1519-566X2008000600013,Less effective than other compounds against T. absoluta,doi_bioActivity
10.1590/S1519-566X2008000600013,"Among the most effective against T. absoluta, causing prolongation of larval development and reduction in larval survival",doi_bioActivity
10.1590/S1519-566X2008000600013,Less effective than other compounds against T. absoluta,doi_bioActivity
10.1590/S1519-566X2008000600013,Less effective than other compounds against T. absoluta,doi_bioActivity
10.1590/S1519-566X2008000600013,"Among the most effective against T. absoluta, causing prolongation of larval development and reduction in larval survival",doi_bioActivity
10.1590/s0100-40422008000700015,"Inhibition of 89.55% against Jurkat (leukemia) and 57.10% against B16F10 (melanoma) tumoral cells at 0.1 mg mL-1 concentration, weak antibacterial activity against Staphylococcus aureus (MIC 120 µg/mL) and Escherichia coli (MIC 189 µg/mL)",doi_bioActivity
10.1590/s0100-40422008000700015,"Not specifically mentioned, but chemically similar to Chaetoglobosin B which is typically cytotoxic",doi_bioActivity
10.1590/s0100-40422008000700015,"Not specifically mentioned, but chemically similar to Chaetoglobosin B which is typically cytotoxic",doi_bioActivity
10.3390/molecules15129205,Acetylcholinesterase inhibition with IC50 value of 0.21 mM,doi_bioActivity
10.3390/molecules15129205,"Acetylcholinesterase inhibition with IC50 value of 2.5 μM, similar to reference compound galanthamine",doi_bioActivity
10.3390/molecules15129205,Acetylcholinesterase inhibition with IC50 value of 46 μM,doi_bioActivity
10.3390/molecules15129205,Acetylcholinesterase inhibition with IC50 value of 1.4 mM,doi_bioActivity
10.3390/molecules15129205,"Acetylcholinesterase inhibition, specific activity not reported",doi_bioActivity
10.3390/molecules15129205,"Acetylcholinesterase inhibition, specific activity not reported",doi_bioActivity
10.3390/molecules190812031,Possible artefact from isolation procedures,doi_bioActivity
10.5935/0100-4042.20140049,Moderate inhibitory activity against cathepsin B with an IC50 of 62.02 µM,doi_bioActivity
10.5935/0100-4042.20140049,Significant toxicity against CNS cancer cell line (SF-295) with IC50 = 36.80 µM and human leukemia (HL-60) with IC50 = 25.37 µM,doi_bioActivity
